These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. The Perception and Attention Functions test battery as a measure of neurocognitive impairment in patients with suspected central disorders of hypersomnolence. Ramm M; Jafarpour A; Boentert M; Lojewsky N; Young P; Heidbreder A J Sleep Res; 2018 Apr; 27(2):273-280. PubMed ID: 28771870 [TBL] [Abstract][Full Text] [Related]
8. Update on hypersomnias of central origin. Drakatos P; Leschziner GD Curr Opin Pulm Med; 2014 Nov; 20(6):572-80. PubMed ID: 25165990 [TBL] [Abstract][Full Text] [Related]
9. Normal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditions. Dauvilliers Y; Delallée N; Jaussent I; Scholz S; Bayard S; Croyal M; Schwartz JC; Robert P Sleep; 2012 Oct; 35(10):1359-66. PubMed ID: 23024434 [TBL] [Abstract][Full Text] [Related]
10. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study. Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422 [TBL] [Abstract][Full Text] [Related]
11. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial. Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166 [TBL] [Abstract][Full Text] [Related]
12. Modulation of vigilance in the primary hypersomnias by endogenous enhancement of GABAA receptors. Rye DB; Bliwise DL; Parker K; Trotti LM; Saini P; Fairley J; Freeman A; Garcia PS; Owens MJ; Ritchie JC; Jenkins A Sci Transl Med; 2012 Nov; 4(161):161ra151. PubMed ID: 23175709 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
15. The effects of armodafinil on objective sleepiness and performance in a shift work disorder sample unselected for objective sleepiness. Howard R; Roth T; Drake CL J Clin Psychopharmacol; 2014 Jun; 34(3):369-73. PubMed ID: 24717254 [TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum of narcolepsy and idiopathic hypersomnia. Aldrich MS Neurology; 1996 Feb; 46(2):393-401. PubMed ID: 8614501 [TBL] [Abstract][Full Text] [Related]
18. From wakefulness to excessive sleepiness: what we know and still need to know. Ohayon MM Sleep Med Rev; 2008 Apr; 12(2):129-41. PubMed ID: 18342261 [TBL] [Abstract][Full Text] [Related]